CVL- 865: A study drug for people with drug-resistant Focal Onset Seizures
This study is open to participants who were in the previous seizure trial numbered CVL-865-SZ-001. This study will give these previous participants open-label treatment with the study drug for 57 weeks. The study drug is called CVL- 865.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Will I be paid for my time?